Bio-Reference Laboratories, Inc. Announces Agreement To Acquire Gene-Based Testing Laboratory, Third Quarter Results And Reaffirms Guidance For Year; Company Signals Major Initiative Into Gene-Based Testing By Acquiring GeneDx

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Aug. 29, 2006--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for GeneDx or Per Share Data or where otherwise noted, Numbers are in Thousands) announced it has executed a Purchase Agreement for the acquisition of GeneDx, a gene-based testing laboratory located in Gaithersburg, MD and released its third quarter, fiscal year 2006 earnings today for the three months ending July 31.